ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others), By Technology (Chemiluminescent, Colorimetric, Fluorescent), By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others), By Region and Competition, 2020-2030F
Market Overview
The Global ELISA Test Market, valued at USD 2.49 Billion in 2024, is projected to experience a CAGR of 7.84% to reach USD 3.92 Billion by 2030. The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical technique primarily employed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones in biological samples. The global ELISA test market's expansion is significantly driven by the escalating prevalence of infectious and chronic diseases, including conditions like HIV and various cancers, which necessitate accurate and timely diagnostic tools. Furthermore, continuous advancements in diagnostic technology, enhancing the sensitivity, specificity, and automation of ELISA assays, contribute substantially to market growth.
Key Market Drivers
The global ELISA Test Market is significantly shaped by the escalating prevalence of infectious and chronic diseases, driving a persistent need for accurate and timely diagnostic solutions. The burden of such conditions necessitates widespread testing, with ELISA assays playing a crucial role in disease surveillance and management. For instance, according to the World Health Organization, as of 30 April 2024, over 7.6 million dengue cases were reported globally in 2024, demonstrating the continuous demand for effective diagnostic tools to monitor and control infectious disease outbreaks. This growing disease landscape directly increases the volume of diagnostic procedures required, thereby expanding the market for ELISA tests globally.
Key Market Challenges
High initial investment costs for advanced ELISA equipment and reagents represent a significant challenging factor in the global ELISA test market. The substantial capital expenditure required for acquiring and maintaining sophisticated ELISA systems can limit the adoption of these diagnostic tools, particularly in healthcare settings with restricted budgets. This directly impedes market growth by creating a barrier to entry for smaller laboratories and those in developing regions. For instance, according to a 2024 Lab Manager Industry and Equipment Trends Survey, 55 percent of respondents cited investment in tools, equipment, and instruments as a top challenge, with 64 percent noting difficulty in securing budget approval for new technology. These financial constraints often force laboratories to extend the lifespan of older, less efficient equipment or forgo advanced automation, impacting their capacity for high-throughput testing and the adoption of newer, more sensitive ELISA assays.
Key Market Trends
Miniaturization and Point-of-Care ELISA Platforms are significantly transforming the global ELISA test market by expanding diagnostic accessibility and speeding up result delivery in various settings. This trend facilitates testing closer to patients, moving beyond traditional centralized laboratories and enabling more immediate clinical decisions. The American Association for Clinical Chemistry (AACC) notably underscored the growing importance of decentralized diagnostic solutions by featuring point-of-care as a key topic at its 2023 Annual Scientific Meeting, encompassing a range of cutting-edge diagnostic tests. This strategic shift responds to the demand for rapid, on-site diagnostics that improve patient management, particularly for conditions requiring frequent monitoring or swift intervention. Abbott, a leading diagnostics company, demonstrated advancements in its point-of-care portfolio, with its second-quarter 2024 results highlighting strong demand for rapid diagnostics used for respiratory diseases, often utilizing compact, near-patient platforms. These advancements are critical for the broader adoption of ELISA technologies in diverse healthcare environments.
Key Market Players
In this report, the Global ELISA Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global ELISA Test Market.
Available Customizations:
Global ELISA Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global ELISA Test Market, valued at USD 2.49 Billion in 2024, is projected to experience a CAGR of 7.84% to reach USD 3.92 Billion by 2030. The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical technique primarily employed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones in biological samples. The global ELISA test market's expansion is significantly driven by the escalating prevalence of infectious and chronic diseases, including conditions like HIV and various cancers, which necessitate accurate and timely diagnostic tools. Furthermore, continuous advancements in diagnostic technology, enhancing the sensitivity, specificity, and automation of ELISA assays, contribute substantially to market growth.
Key Market Drivers
The global ELISA Test Market is significantly shaped by the escalating prevalence of infectious and chronic diseases, driving a persistent need for accurate and timely diagnostic solutions. The burden of such conditions necessitates widespread testing, with ELISA assays playing a crucial role in disease surveillance and management. For instance, according to the World Health Organization, as of 30 April 2024, over 7.6 million dengue cases were reported globally in 2024, demonstrating the continuous demand for effective diagnostic tools to monitor and control infectious disease outbreaks. This growing disease landscape directly increases the volume of diagnostic procedures required, thereby expanding the market for ELISA tests globally.
Key Market Challenges
High initial investment costs for advanced ELISA equipment and reagents represent a significant challenging factor in the global ELISA test market. The substantial capital expenditure required for acquiring and maintaining sophisticated ELISA systems can limit the adoption of these diagnostic tools, particularly in healthcare settings with restricted budgets. This directly impedes market growth by creating a barrier to entry for smaller laboratories and those in developing regions. For instance, according to a 2024 Lab Manager Industry and Equipment Trends Survey, 55 percent of respondents cited investment in tools, equipment, and instruments as a top challenge, with 64 percent noting difficulty in securing budget approval for new technology. These financial constraints often force laboratories to extend the lifespan of older, less efficient equipment or forgo advanced automation, impacting their capacity for high-throughput testing and the adoption of newer, more sensitive ELISA assays.
Key Market Trends
Miniaturization and Point-of-Care ELISA Platforms are significantly transforming the global ELISA test market by expanding diagnostic accessibility and speeding up result delivery in various settings. This trend facilitates testing closer to patients, moving beyond traditional centralized laboratories and enabling more immediate clinical decisions. The American Association for Clinical Chemistry (AACC) notably underscored the growing importance of decentralized diagnostic solutions by featuring point-of-care as a key topic at its 2023 Annual Scientific Meeting, encompassing a range of cutting-edge diagnostic tests. This strategic shift responds to the demand for rapid, on-site diagnostics that improve patient management, particularly for conditions requiring frequent monitoring or swift intervention. Abbott, a leading diagnostics company, demonstrated advancements in its point-of-care portfolio, with its second-quarter 2024 results highlighting strong demand for rapid diagnostics used for respiratory diseases, often utilizing compact, near-patient platforms. These advancements are critical for the broader adoption of ELISA technologies in diverse healthcare environments.
Key Market Players
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- bioM?rieux India Private Limited
- Enzo Biochem Inc.
- BioLegend, Inc.
- ELISA Technologies, Inc.
- RayBiotech, Inc.
- Eurofins Scientific (Ireland) Limited
In this report, the Global ELISA Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- ELISA Test Market, By Method:
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
- ELISA Test Market, By Application:
- Vaccine Development
- Immunology
- Diagnostics
- Toxicology
- Drug Monitoring and Pharmaceutical Industry
- Transplantation
- Others
- ELISA Test Market, By Technology:
- Chemiluminescent
- Colorimetric
- Fluorescent
- ELISA Test Market, By End User:
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Others
- ELISA Test Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global ELISA Test Market.
Available Customizations:
Global ELISA Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ELISA TEST MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)
5.2.2. By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others)
5.2.3. By Technology (Chemiluminescent, Colorimetric, Fluorescent)
5.2.4. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA ELISA TEST MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method
6.2.2. By Application
6.2.3. By Technology
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States ELISA Test Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Method
6.3.1.2.2. By Application
6.3.1.2.3. By Technology
6.3.1.2.4. By End User
6.3.2. Canada ELISA Test Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Method
6.3.2.2.2. By Application
6.3.2.2.3. By Technology
6.3.2.2.4. By End User
6.3.3. Mexico ELISA Test Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Method
6.3.3.2.2. By Application
6.3.3.2.3. By Technology
6.3.3.2.4. By End User
7. EUROPE ELISA TEST MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method
7.2.2. By Application
7.2.3. By Technology
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany ELISA Test Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Method
7.3.1.2.2. By Application
7.3.1.2.3. By Technology
7.3.1.2.4. By End User
7.3.2. France ELISA Test Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Method
7.3.2.2.2. By Application
7.3.2.2.3. By Technology
7.3.2.2.4. By End User
7.3.3. United Kingdom ELISA Test Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Method
7.3.3.2.2. By Application
7.3.3.2.3. By Technology
7.3.3.2.4. By End User
7.3.4. Italy ELISA Test Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Method
7.3.4.2.2. By Application
7.3.4.2.3. By Technology
7.3.4.2.4. By End User
7.3.5. Spain ELISA Test Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Method
7.3.5.2.2. By Application
7.3.5.2.3. By Technology
7.3.5.2.4. By End User
8. ASIA PACIFIC ELISA TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Method
8.2.2. By Application
8.2.3. By Technology
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China ELISA Test Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Method
8.3.1.2.2. By Application
8.3.1.2.3. By Technology
8.3.1.2.4. By End User
8.3.2. India ELISA Test Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Method
8.3.2.2.2. By Application
8.3.2.2.3. By Technology
8.3.2.2.4. By End User
8.3.3. Japan ELISA Test Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Method
8.3.3.2.2. By Application
8.3.3.2.3. By Technology
8.3.3.2.4. By End User
8.3.4. South Korea ELISA Test Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Method
8.3.4.2.2. By Application
8.3.4.2.3. By Technology
8.3.4.2.4. By End User
8.3.5. Australia ELISA Test Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Method
8.3.5.2.2. By Application
8.3.5.2.3. By Technology
8.3.5.2.4. By End User
9. MIDDLE EAST & AFRICA ELISA TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method
9.2.2. By Application
9.2.3. By Technology
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia ELISA Test Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Method
9.3.1.2.2. By Application
9.3.1.2.3. By Technology
9.3.1.2.4. By End User
9.3.2. UAE ELISA Test Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Method
9.3.2.2.2. By Application
9.3.2.2.3. By Technology
9.3.2.2.4. By End User
9.3.3. South Africa ELISA Test Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Method
9.3.3.2.2. By Application
9.3.3.2.3. By Technology
9.3.3.2.4. By End User
10. SOUTH AMERICA ELISA TEST MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Method
10.2.2. By Application
10.2.3. By Technology
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil ELISA Test Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Method
10.3.1.2.2. By Application
10.3.1.2.3. By Technology
10.3.1.2.4. By End User
10.3.2. Colombia ELISA Test Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Method
10.3.2.2.2. By Application
10.3.2.2.3. By Technology
10.3.2.2.4. By End User
10.3.3. Argentina ELISA Test Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Method
10.3.3.2.2. By Application
10.3.3.2.3. By Technology
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ELISA TEST MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. Becton, Dickinson and Company
15.4. Bio-Rad Laboratories, Inc.
15.5. bioM?rieux India Private Limited
15.6. Enzo Biochem Inc.
15.7. BioLegend, Inc.
15.8. ELISA Technologies, Inc.
15.9. RayBiotech, Inc.
15.10. Eurofins Scientific (Ireland) Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ELISA TEST MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)
5.2.2. By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others)
5.2.3. By Technology (Chemiluminescent, Colorimetric, Fluorescent)
5.2.4. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA ELISA TEST MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method
6.2.2. By Application
6.2.3. By Technology
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States ELISA Test Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Method
6.3.1.2.2. By Application
6.3.1.2.3. By Technology
6.3.1.2.4. By End User
6.3.2. Canada ELISA Test Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Method
6.3.2.2.2. By Application
6.3.2.2.3. By Technology
6.3.2.2.4. By End User
6.3.3. Mexico ELISA Test Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Method
6.3.3.2.2. By Application
6.3.3.2.3. By Technology
6.3.3.2.4. By End User
7. EUROPE ELISA TEST MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method
7.2.2. By Application
7.2.3. By Technology
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany ELISA Test Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Method
7.3.1.2.2. By Application
7.3.1.2.3. By Technology
7.3.1.2.4. By End User
7.3.2. France ELISA Test Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Method
7.3.2.2.2. By Application
7.3.2.2.3. By Technology
7.3.2.2.4. By End User
7.3.3. United Kingdom ELISA Test Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Method
7.3.3.2.2. By Application
7.3.3.2.3. By Technology
7.3.3.2.4. By End User
7.3.4. Italy ELISA Test Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Method
7.3.4.2.2. By Application
7.3.4.2.3. By Technology
7.3.4.2.4. By End User
7.3.5. Spain ELISA Test Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Method
7.3.5.2.2. By Application
7.3.5.2.3. By Technology
7.3.5.2.4. By End User
8. ASIA PACIFIC ELISA TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Method
8.2.2. By Application
8.2.3. By Technology
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China ELISA Test Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Method
8.3.1.2.2. By Application
8.3.1.2.3. By Technology
8.3.1.2.4. By End User
8.3.2. India ELISA Test Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Method
8.3.2.2.2. By Application
8.3.2.2.3. By Technology
8.3.2.2.4. By End User
8.3.3. Japan ELISA Test Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Method
8.3.3.2.2. By Application
8.3.3.2.3. By Technology
8.3.3.2.4. By End User
8.3.4. South Korea ELISA Test Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Method
8.3.4.2.2. By Application
8.3.4.2.3. By Technology
8.3.4.2.4. By End User
8.3.5. Australia ELISA Test Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Method
8.3.5.2.2. By Application
8.3.5.2.3. By Technology
8.3.5.2.4. By End User
9. MIDDLE EAST & AFRICA ELISA TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method
9.2.2. By Application
9.2.3. By Technology
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia ELISA Test Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Method
9.3.1.2.2. By Application
9.3.1.2.3. By Technology
9.3.1.2.4. By End User
9.3.2. UAE ELISA Test Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Method
9.3.2.2.2. By Application
9.3.2.2.3. By Technology
9.3.2.2.4. By End User
9.3.3. South Africa ELISA Test Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Method
9.3.3.2.2. By Application
9.3.3.2.3. By Technology
9.3.3.2.4. By End User
10. SOUTH AMERICA ELISA TEST MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Method
10.2.2. By Application
10.2.3. By Technology
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil ELISA Test Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Method
10.3.1.2.2. By Application
10.3.1.2.3. By Technology
10.3.1.2.4. By End User
10.3.2. Colombia ELISA Test Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Method
10.3.2.2.2. By Application
10.3.2.2.3. By Technology
10.3.2.2.4. By End User
10.3.3. Argentina ELISA Test Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Method
10.3.3.2.2. By Application
10.3.3.2.3. By Technology
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ELISA TEST MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. Becton, Dickinson and Company
15.4. Bio-Rad Laboratories, Inc.
15.5. bioM?rieux India Private Limited
15.6. Enzo Biochem Inc.
15.7. BioLegend, Inc.
15.8. ELISA Technologies, Inc.
15.9. RayBiotech, Inc.
15.10. Eurofins Scientific (Ireland) Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
